Savolitinib (AZD-6094) is a potent and selective, oral bioavailability inhibitor with ICs of 5 nM and 3 nM for c-Met and p-Met, respectively.Savolitinib (AZD-6094) selectively binds and inhibits c-Met activation in an ATP-competitive manner, disrupting the c-Met signaling pathway. It has anti-tumor activity.
Chemical Properties
Physical Appearance
A solid
Storage
-20°C
M.Wt
345.36
Cas No.
1313725-88-0
Formula
C17H15N9
Synonyms
Volitinib;HMPL-504;AZD-6094
Solubility
≥10.5 mg/mL in DMSO with ultrasonic; insoluble in EtOH; insoluble in H2O